Skip to main content
. 2024 Mar 6;23:91. doi: 10.1186/s12933-024-02141-1

Table 1.

Baseline characteristics

LEAVE-DM (n = 178) Vic-ELF (n = 97) p
Age, years 72 [69–76] 70 [68–73]  < 0.001
Female (%) 73 (41.0) 42 (43.3) 0.71
CCI, score 5 [46] 1 [1, 2]  < 0.001
SBP, mmHg 145 [134–155] 141 [130–150] 0.04
DBP, mmHg 77 [70–85] 85 [78–90]  < 0.001
HR, bpm 71 [64–83] 71 [65–79] 0.63
BMI, kg/m2 29.9 [27.3–34.5] 31.0 [27.4–33.9] 0.66
ARIC HF, score 13.8 [8.0–22.8] 9.7 [6.5–14.7]  < 0.001
Obesity (%) 82 (46.6) 58 (59.8) 0.04
Hypertension (%) 126 (70.8) 80 (82.5) 0.03
Type 2 diabetes (%) 178 (100) 97 (100)
Peripheral vascular disease (%) 10 (5.7) 1 (1.0) 0.06
Family history of CAD (%) 95 (53.7) 25 (25.8)  < 0.001
Family history of HF (%) 31 (17.6) 4 (4.1) 0.001
NT-proBNP (pg/mL) 93.0 [50.7–228.3] 43.0 [30.3–88.5]  < 0.001
LVMI (g/m2) 82.0 [70.8–98.5] 70.4 [56.6–83.6]  < 0.001
Ejection fraction (%) 59.0 [54.0–62.0] 60.1 [56.6–66.0] 0.004
GLS (−%) 17.4 [16.0–19.2] 18.0 [16.7–20.0] 0.005
E/e′ 9.5 [7.9–11.5] 8.5 [7.4–10.7] 0.02
LAVI (mL/m2) 30.6 [27.1–40.3] 33.4 [28.3–40.4] 0.19
E/A 0.8 [0.7–0.9] 0.8 [0.7–0.9] 0.93
QOL, score 83 [71–93] 80 [70–90] 0.03
RR interval (ms) 873 [750–977] 893 [817–995] 0.064
PR interval (ms) 170 [156–186] 176 [161–188] 0.142
QRS duration (ms) 90 [84–102] 94 [86–104] 0.291
QT duration (ms) 394 [375–422] 400 [380–424] 0.157
QTc interval (ms) 426 [411–440] 425 [411–439] 0.707

Continuous variables are given as median [IQR]

CCI: Charlson Comorbidity Index; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; BMI: body mass index; ARIC HF: Atherosclerosis Risk in Communities Heart Failure score; CAD: coronary artery disease; HF: heart failure; NT-proBNP: N-terminal prohormone of brain natriuretic peptide; LVMI: left ventricular mass index; GLS: global longitudinal strain; LAVI: left atrial volume index; QOL: quality of life